Literature DB >> 7436809

Congenital myotonic dystrophy: fiber type abnormalities in two cases.

Z Argov, D Gardner-Medwin, M A Johnson, F L Mastaglia.   

Abstract

Histometric data on muscle fiber types were studied in two cases of congenital myotonic dystrophy (CMD); one underwent biopsy at the age of 5 months and the other at the age of 10 years. A previously unreported severe deficiency of type IIB fibers were found in both cases. In addition, in the first case, there was type I fiber preponderance and hypotrophy as described in cases of congenital fiber type disproportion (CFTD). It is suggested that an abnormality of motor unit maturation may be common to CMD and to CFTD, and that this results from a disorder of neural trophic influences during muscle development.

Entities:  

Mesh:

Year:  1980        PMID: 7436809     DOI: 10.1001/archneur.1980.00500600041006

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  4 in total

1.  Muscle fibre type composition, motoneuron firing properties, axonal conduction velocity and refractory period for foot extensor motor units in dystrophia myotonica.

Authors:  J Borg; L Edström; G S Butler-Browne; L E Thornell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-08       Impact factor: 10.154

2.  Mitochondrial DNA does not appear to influence the congenital onset type of myotonic dystrophy.

Authors:  J Poulton; H G Harley; J Dasmahapatra; G K Brown; C G Potter; B Sykes
Journal:  J Med Genet       Date:  1995-09       Impact factor: 6.318

3.  Variation in mitochondrial DNA levels in muscle from normal controls. Is depletion of mtDNA in patients with mitochondrial myopathy a distinct clinical syndrome.

Authors:  J Poulton; C Sewry; C G Potter; T Bougeron; D Chretien; F A Wijburg; K J Morten; G Brown
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 4.  Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy.

Authors:  Laurène M André; C Rosanne M Ausems; Derick G Wansink; Bé Wieringa
Journal:  Front Neurol       Date:  2018-05-28       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.